Today’s editorial is shortened and moved from the front-page to leave room for the joint press release from Novo Nordisk, the EASD and the JDF, granting a total of US $ 10.5 for European research to find a cure for diabetes. The new European research
initiative will include both Type 1 and Type 2 diabetes and is planned to run for a three-year period.
The meeting is now on its third day and is still doing extremely well. What we hear from outside the lecture halls and in the exhibition areas is that the Organising Committee and the Programme Committee have done a very good job. On top of this, we have already had two excellent honorary presentations, the A.M. Cohen Lecture by Professor Paul Zimmet on Monday and the Camillo Golgi Lecture by Professor Umberto Di Mario.
This afternoon we look forward to hearing the Minkowski Lecture by H. Edlund, entitled “Factors controlling ß-cell identity and glucose homeostasis”.
Finally, as the last session tomorrow, the Claude Bernard Lecture will be held by W. Malaisse, entitled “On the track to the ß-cell”.
Please enjoy the rest of the meeting, as well as this Daily Review service.